Apoptosis

, Volume 12, Issue 3, pp 613–622

Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours

  • Jane L. Armstrong
  • Gareth J. Veal
  • Christopher P. F. Redfern
  • Penny E. Lovat
Article

Abstract

Fenretinide-induced apoptosis of neuroectodermal tumour cells is mediated through generation of reactive oxygen species (ROS), endoplasmic reticulum (ER) stress, mitochondrial cytochrome c release and caspase activation. The present study describes the requirement of the BH3-domain only protein Noxa for this process and its regulation by p53. Noxa expression was induced by fenretinide in neuroblastoma and melanoma cells, including those with mutated p53, and this induction was abolished by antioxidants. Knockdown of p53 by RNA interference (RNAi) demonstrated upregulation of Noxa protein levels in response to fenretinide was p53-independent, although evidence suggested that Noxa may be transcriptionally regulated by p53. The ER stress-inducing agent thapsigargin also induced p53-independent Noxa expression. Conversely, Noxa transcription in response to the chemotherapeutic agents cisplatin or temozolomide was inhibited by p53 knockdown. Apoptosis in response to cisplatin or temozolomide was also inhibited by abrogation of p53 expression yet apoptosis in response to fenretinide or thapsigargin was unaffected. RNAi-mediated down-regulation of Noxa inhibited apoptosis in response to fenretinide or thapsigargin, whereas apoptosis induced by cisplatin or temozolomide was unaffected. These data demonstrate the importance of Noxa induction in determining the apoptotic response to fenretinide and emphasise the role of Noxa in p53-independent apoptosis.

Keywords

Neuroblastoma Melanoma Fenretinide Noxa 

References

  1. 1.
    Garaventa A, Luksch R, Lo Piccolo MS et al (2003) Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res 9:2032–2039PubMedGoogle Scholar
  2. 2.
    Corazzari M, Lovat PE, Oliverio S et al (2005) Fenretinide: a p53-independent way to kill cancer cells. Biochem Biophys Res Commun 331:810–815PubMedCrossRefGoogle Scholar
  3. 3.
    Lovat PE, Ranalli M, Annichiarrico-Petruzzelli M et al (2000) Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma. 260:50–60Google Scholar
  4. 4.
    Tiwari M, Kumar A, Sinha RA et al (2006) Mechanism of 4-HPR induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress. Carcinogenesis (In Press)Google Scholar
  5. 5.
    Amiri KI, Horton LW, LaFleur BJ, Sosman JA, Richmond A (2004) Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. Cancer Res 64:4912–4918PubMedCrossRefGoogle Scholar
  6. 6.
    Michaelis M, Fichtner I, Behrens D et al (2006) Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo. Int J Oncol 28:439–446PubMedGoogle Scholar
  7. 7.
    Perez-Galan P, Roue G, Villamor N, Montserrat E, Campo E, Colomer D (2006) The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 107:257–264PubMedCrossRefGoogle Scholar
  8. 8.
    Fernandez Y, Verhaegen M, Miller TP et al (2005) Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 65:6294–6304PubMedCrossRefGoogle Scholar
  9. 9.
    Seo Y, Shin JN, Ko KH et al (2003) The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. J Biol Chem 278:48292–48299PubMedCrossRefGoogle Scholar
  10. 10.
    Oda E, Ohki R, Murasawa H et al (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053–1058PubMedCrossRefGoogle Scholar
  11. 11.
    Villunger A, Michalak EM, Coultas L et al (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302:1036–1038PubMedCrossRefGoogle Scholar
  12. 12.
    Jullig M, Zhang WV, Ferreira A, Stott NS (2006) MG132 induced apoptosis is associated with p53-indpendent induction of pro-apoptotic Noxa and transcriptional activity of β-catenin. Apoptosis 11:627–641PubMedCrossRefGoogle Scholar
  13. 13.
    Futami T, Miyagishi M, Taira K (2005) Identification of a network involved in thapsigargin-induced apoptosis using a library of small interfering RNA expression vectors. J Biol Chem 280:826–831PubMedGoogle Scholar
  14. 14.
    Lovat PE, Di Sano R, Corazzari M et al (2004) Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide. J Natl Cancer Inst 96:1288–1299PubMedCrossRefGoogle Scholar
  15. 15.
    Gimeno R, Weijer K, Voordouw A et al (2004) Monitoring the effect of gene silencing by RNA interference in human CD34+cells injected into newborn RAG2−/− gammac−/− mice: functional inactivation of p53 in developing T cells. Blood 104:3886–3893PubMedCrossRefGoogle Scholar
  16. 16.
    Li J, Lee B, Lee AS (2006) Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J Biol Chem 281:7260–7270PubMedCrossRefGoogle Scholar
  17. 17.
    Wei JS, Whiteford CC, Cenacchi N, Son CG, Khan J (2005) BBC3 mediates fenretinide-induced cell death in neuroblastoma. Oncogene 24:7976–7983PubMedCrossRefGoogle Scholar
  18. 18.
    England K, ‘driscoll CO, Cotter TG (2006) ROS and protein oxidation in early stages of cytotoxic drug induced apoptosis. Free Radic Res 40:1124–1137PubMedCrossRefGoogle Scholar
  19. 19.
    Xu C, Bailly-Maitre B, Reed JC (2005) Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115:2656–2664PubMedCrossRefGoogle Scholar
  20. 20.
    Reimertz C, Kogel D, Rami A, Chittenden T, Prehn JH (2003) Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. J Cell Biol 162:587–597PubMedCrossRefGoogle Scholar
  21. 21.
    Willis SN, Adams JM (2005) Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17:617–625PubMedCrossRefGoogle Scholar
  22. 22.
    Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW (2006) p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9:45–56PubMedCrossRefGoogle Scholar
  23. 23.
    Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH (2004) BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 199:113–124PubMedCrossRefGoogle Scholar
  24. 24.
    Hershko T, Ginsberg D (2004) Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 279:8627–8634PubMedCrossRefGoogle Scholar
  25. 25.
    Qu L, Huang S, Baltzis D et al (2004) Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta. Genes Dev 18:261–277PubMedCrossRefGoogle Scholar
  26. 26.
    Hussein MR, Haemel AK, Wood GS (2003) Apoptosis and melanoma: molecular mechanisms. J Pathol 199:275–288PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Jane L. Armstrong
    • 1
  • Gareth J. Veal
    • 1
  • Christopher P. F. Redfern
    • 1
  • Penny E. Lovat
    • 1
    • 2
  1. 1.Northern Institute for Cancer Research, School of Clinical and Laboratory SciencesNewcastle UniversityNewcastle Upon TyneUK
  2. 2.Dermatological SciencesSchool of Clinical and Laboratory Sciences, Newcastle UniversityNewcastle upon TyneUK

Personalised recommendations